Allogene Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.

About ALLO

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. 

CEO
David D. Chang
CEODavid D. Chang
Employees
310
Employees310
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2017
Founded2017
Employees
310
Employees310

ALLO Key Statistics

Market cap
1.62B
Market cap1.62B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.58M
Average volume2.58M
High today
$11.56
High today$11.56
Low today
$10.97
Low today$10.97
Open price
$11.04
Open price$11.04
Volume
1.89M
Volume1.89M
52 Week high
$26.14
52 Week high$26.14
52 Week low
$6.43
52 Week low$6.43

Analyst ratings

74%

of 19 ratings
Buy
73.7%
Hold
26.3%
Sell
0%

ALLO Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.